Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Evolution of treatment patterns and survival outcomes in patients with advanced non-small cell lung cancer treated at Frankfurt University Hospital in 2012–2018

Fig. 3

Overall survival for patients with NSQ/other (A) or SQ (B) histology receiving a first line of therapy in the pre-ICI and post-ICI periods. Index date represents the start of first-line therapy. CI Confidence interval, ICI Immune checkpoint inhibitor, NSQ Non-squamous cell, OS Overall survival, SQ Squamous cell

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us